OpenEvidence 与 Memorial Sloan Kettering 合作将 OncoKB 接入平台
精选理由
MSK 把 OncoKB 肿瘤基因专家注释直接搬进了 OpenEvidence，医生查肿瘤突变解读不用再切工具了。
Memorial Sloan Kettering（MSK）将 OncoKB 集成进 OpenEvidence。OncoKB 是 MSK 对肿瘤基因突变的专家解读知识库。医生在 OpenEvidence 中查询时可直接获得 OncoKB 的肿瘤遗传学临床注释。OpenEvidence 此前主要面向医疗场景提供循证检索，接入后覆盖肿瘤基因组学解读环节。
原文 · Sarah Guo
Big counterattack in the fight against cancer. Memorial Sloan Kettering is a gold standard for cutting edge cancer care. Now @OpenEvidence and MSK have built OncoKB, MSK’s expert interpretation of a tumor’s genetics, directly into OpenEvidence!
